ESC 365 - ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study.

Back

ESC Premium Access

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study.

Session: Hot Line Session 5

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor B. Schrage (Hamburg, DE)

Event: ESC CONGRESS 2019

Congress Session

About the speaker

Doctor Benedikt Schrage

University Heart Centre Hamburg, Hamburg (Germany)

5 presentations

0 follower

12 more presentations in this session

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommended therapies. Final 5-year results from the CLARIFY study

Speaker: Doctor E. Sorbets (Paris, FR)

Discussant review - CLARIFY

Speaker: Professor D. Hasdai (Petah Tikva, IL)

Questions from the audience and discussion

Access

Video

SWEDEHEART - Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Speaker: Doctor E. Bjoerklund (Gothenburg, SE)

Discussant review - SWEDEHEART

Speaker: Professor V. Falk (Berlin, DE)

Access

Slides

Video

Access the full session

Hot Line Session 5

Speakers: Doctor B. Schrage, Doctor E. Sorbets, Professor D. Hasdai, Doctor E. Bjoerklund, Professor V. Falk

Access

About the event

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study.

About the speaker

Doctor Benedikt Schrage

12 more presentations in this session

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommended therapies. Final 5-year results from the CLARIFY study

Discussant review - CLARIFY

Questions from the audience and discussion

SWEDEHEART - Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Discussant review - SWEDEHEART

Access the full session

Hot Line Session 5

About the event

ESC CONGRESS 2019

This platform is supported by